…
comment: The repository administrator has not yet configured an RDF license.
primary topic: SPECIFICITY OF TREATMENT OF PEPTIC ULCER DISEASE WITH H2 HISTAMINE BLOCKER DRUGS

SPECIFICITY OF TREATMENT OF PEPTIC ULCER DISEASE WITH H2 HISTAMINE BLOCKER DRUGS
type: AcademicArticle
type: Article
abstract: Peptic ulcer disease (PUD) is a chronic condition characterized by mucosal erosion in the stomach or duodenum, resulting from an imbalance between aggressive gastric factors such as acid and pepsin, and defensive mechanisms including mucosal protection, prostaglandin secretion, and epithelial regeneration. Among the major therapeutic milestones in its treatment is the introduction of H₂ histamine receptor antagonists (H₂ blockers), which revolutionized gastroenterology by suppressing acid secretion effectively and promoting mucosal healing. This paper discusses the pharmacodynamics, pharmacokinetics, therapeutic specificity, and clinical implications of H₂ blockers such as cimetidine, ranitidine, famotidine, and nizatidine in the management of peptic ulcer disease. Emphasis is placed on their mechanism of action, comparative efficacy, drug interactions, side effects, and their role in the contemporary era of proton pump inhibitors (PPIs).
date: 2025-10-29
status: published
author list: authors
type: EPrint
type: ArticleEPrint
is part of: repository

Center for Tech and Media Research
type: Organization

Multidisciplinary Journal of Science and Technology
type: Collection

Sobirjonov Islombek
type: Person
given name: Sobirjonov
family name: Islombek

HTML Summary of #63147 SPECIFICITY OF TREATMENT OF PEPTIC ULCER DISEASE WITH H2 HISTAMINE BLOCKER DRUGS
format: text/html
primary topic: SPECIFICITY OF TREATMENT OF PEPTIC ULCER DISEASE WITH H2 HISTAMINE BLOCKER DRUGS